Loading Results

We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Find Clinical Trials & Studies

Visit the Research & Education Institute

SATURN - RES515329

Back to Search Results

I'm Interested!

Fill out our online form

STATINS USE IN INTRACEREBRAL HEMORRHAGE PATIENTS

Sex at Birth: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Others
Trial Phase: Phase III
Conditions Being Studied: Brain Cerebral Hemorrhage

Study Purpose

The SATURN trial aims to determine whether continuation vs. discontinuation of statin drugs after spontaneous lobar intracerebral hemorrhage (ICH) is the best strategy; and whether the decision to continue/discontinue statins should be influenced by an individual's Apolipoprotein-E (APOE) genotype.

Who Can Participate

Age: 50 and older

Principal Investigator
Abhishek Ray MD

Department/Division
Stroke (Neurology)

Locations

University Hospitals Mentor Health Center
9485 Mentor Ave.
Mentor OH, 44060

UH Minoff Health Center at Chagrin Highlands
3909 Orange Place
Orange Village OH, 44122

UH Ahuja Medical Center
3999 Richmond Road
Beachwood OH, 44122

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

UH Westlake Health Center
960 Clague Road
Westlake OH, 44145

UH IRB: SITE00001154
StudyID: 2020-0239
ClinicalTrials.gov: NCT03936361

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422